Azoicăi D, Ivan A, Carasievici E, Luca V, Ilcenco D, Scripcaru L, Scripcariu D, Grigoriu-Merchez M
Gr.T. Popa University of Medicine and Pharmacy Iasi.
Rev Med Chir Soc Med Nat Iasi. 2001 Jan-Mar;105(1):127-31.
The paper describes aspects in the natural evolution of hepatitis C virus (HCV) infection with severe outcomes induced by the typical or atypical clinical manifestations or chronic carrier state. In the interval 1995-1999 in the Iasi district morbidity from all types of viral hepatitis ranged from 153.4 cases per 100,000 inhabitants in 1995 to 66.6 in 1999. The features of A viral hepatitis epidemiological process was the multiannual cyclic pattern. From estimating the circulation of HCV in the population of Iasi district, several population categories have been screened for the presence of HCV antibodies (anti-HCV). Testing 87,894 blood samples assessed the prevalence of anti-HCV in blood donors. Different annual values resulted: 1.5% in 1997 and as a result of routine screening, only 0.3% in 1999. The cases of posttransfusion hepatitis (PTH) admitted to the Clinic of Infectious Diseases of Iasi, the diagnosis of which was supported by epidemiological history and confirmed serologically by the presence of anti-HCV were of 12 in 1995 (36.4% of all PTH), 20 in the interval 1996-1999, with an average for the 4 study years of 7.5%. Anti-HCV was found in 24.4% of series of 4,594 patients with viral hepatitis, in 32.1% of 582 individuals with various disorders or at risk, of which those with liver cirrhosis accounted for 37%, and in 9.6% of 94 patients with neurological disorders. Of the 1083 tested physicians and nurses working in health care settings at risk 6.6% were anti-HCV-positive.
本文描述了丙型肝炎病毒(HCV)感染自然演变过程中的一些方面,这些感染由典型或非典型临床表现或慢性携带状态导致严重后果。1995年至1999年期间,在雅西地区,各类病毒性肝炎的发病率从1995年的每10万居民153.4例降至1999年的66.6例。甲型病毒性肝炎流行病学过程的特点是多年周期性模式。通过估计HCV在雅西地区人群中的传播情况,对几类人群进行了HCV抗体(抗-HCV)筛查。检测了87894份血样以评估献血者中抗-HCV的流行率。得出了不同的年度值:1997年为1.5%,而由于常规筛查,1999年仅为0.3%。入住雅西传染病诊所的输血后肝炎(PTH)病例中,1995年有12例(占所有PTH的36.4%),其诊断有流行病学史支持且通过抗-HCV的存在血清学确诊,1996年至1999年期间有20例,4个研究年度的平均比例为7.5%。在4594例病毒性肝炎患者系列中,24.4%检测出抗-HCV;在582例患有各种疾病或处于风险中的个体中,32.1%检测出抗-HCV,其中肝硬化患者占37%;在94例神经系统疾病患者中,9.6%检测出抗-HCV。在1083名在有风险的医疗环境中工作的医生和护士中,6.6%抗-HCV呈阳性。